Open-Systems-Pharmacology/Forum

CYP3A4 DDI

Closed this issue · 0 comments

When modeling CYP3A4-mediated DDI, there is a significant change in Cmax and almost constant AUC after drug combination.
What parameters can be adjusted?

Or there is a significant change in AUC but no change in Cmax. What parameters can be adjusted?